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Marburg virus (MARV) is a lipid-enveloped virus from the
Filoviridae family containing a negative sense RNA genome.
One of the sevenMARVgenes encodes thematrix proteinVP40,
which forms amatrix layer beneath the plasmamembrane inner
leaflet to facilitate budding from the host cell. MARV VP40
(mVP40) has been shown tobe adimeric peripheral proteinwith
a broad and flat basic surface that can associate with anionic
phospholipids such as phosphatidylserine. Although a number
of mVP40 cationic residues have been shown to facilitate bind-
ing tomembranes containing anionic lipids, much less is known
on how mVP40 assembles to form the matrix layer following
membrane binding. Here we have used hydrogen/deuterium
exchange (HDX) mass spectrometry to determine the solvent
accessibility of mVP40 residues in the absence and presence of
phosphatidylserine and phosphatidylinositol 4,5-bisphosphate.
HDX analysis demonstrates that two basic loops in the mVP40
C-terminal domain make important contributions to anionic
membrane binding and also reveals a potential oligomerization
interface in the C-terminal domain as well as a conserved oligo-
merization interface in the mVP40 N-terminal domain. Lipid
binding assays confirm the role of the two basic patches
elucidated with HD/X measurements, whereas molecular
dynamics simulations and membrane insertion measure-
ments complement these studies to demonstrate that mVP40
does not appreciably insert into the hydrocarbon region of
anionic membranes in contrast to the matrix protein from
Ebola virus. Taken together, we propose a model by which
association of the mVP40 dimer with the anionic plasma
membrane facilitates assembly of mVP40 oligomers.
Marburg virus (MARV)3 belongs to the Filoviridae family like
its cousin the Ebola virus (EBOV) (1). These viruses cause hem-
orrhagic fever in human and non-human primates causing high
fatality rates, which have reached as high as 90% in some out-
breaks (2, 3). To date, there are no FDA approved drugs to treat
EBOV or MARV infection, despite several therapeutic ap-
proaches employed during the 2013–2016 EBOV outbreak in
West Africa (4).
EBOV andMARV are lipid-enveloped viruses and their lipid
envelope is extracted from the host cell plasma membrane
when the nascent viral particles bud out from the host cell
(5). The matrix protein VP40 is a peripheral protein located
beneath the lipid envelope providing structural stability to the
viral particle and a protein matrix layer to facilitate budding of
virions from the plasma membrane. Expression of VP40 as the
only filovirus protein in mammalian cells is sufficient to form
filamentous structures referred to as viral like particles (VLPs)
that closely resemble the authentic viruses (6, 7). MARV VP40
(mVP40) is able to recruit MARV glycoprotein (GP), which is a
transmembrane protein found on the viral envelope, to sites of
budding (8). mVP40 is also able to interact with the nucleocap-
sid of the virus, which encapsulates the negative sense RNA
genome of the virus (9). Phosphorylation of mVP40 at specific
tyrosine residues also facilitates recruitment of the nucleocap-
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Recent crystal structure determination of mVP40 found that
like Ebola VP40 (eVP40), mVP40 exists as a dimer and contains
a N-terminal (NTD) with an -helical dimer interface and a
C-terminal domain (CTD) that mediates membrane binding
(11). In addition to the eVP40 dimer, eVP40 forms other oligo-
meric states, which have been crystalized (12). Through hydro-
phobic CTD-CTD interactions eVP40 dimers can further
assemble into hexamers that have been shown to be crucial for
viral matrix assembly and budding (12). eVP40 dimers were
shown to assemble into hexamers via the CTD-CTD interface
as well as aNTD interface that is somewhat buried in the dimer.
A conformational change is hypothesized to occur in eVP40
monomers or dimers, which would exclude the monomers at
the ends of the hexamer, displacing the CTD from the NTD
revealing the oligomerization site.
This conformational displacement exposes a residue, which
was much more buried in the dimer, Trp95. Trp95 forms the
integral part of the NTD oligomerization interface along with
Glu160. These residues allow the NTDs to assemble the central
core of the hexamer. These rearranged hexamers further as-
semble into long filamentous structures that form the matrix
layer and facilitate the budding process (12). Significant oligo-
merization of eVP40 was hypothesized to occur at the plasma
membrane as an anionic membrane mimetic, dextran sulfate,
induced this VP40 structural rearrangement (12). In agreement
with this hypothesis, VP40 hexamers and larger oligomers have
been observed at the plasma membrane inner leaflet where the
matrix assembly and budding take place (13–15). Apart from
the hexamer, eVP40 also forms an octameric ring structure that
binds RNA and this RNA interaction with the eVP40 octamer
was shown to be important for the viral life cycle (12, 16). To
date, only themVP40 dimer structure has been solved and thus
much less information is available on how mVP40 may oli-
gomerize in the presence of membranes.
The NTD of mVP40 is similar to eVP40 sharing 42% se-
quence identities and similar folds. The NTD-NTD dimer
interface interactions are shown to be important for viral
assembly and budding as mutation of threonine (Thr105) at the
dimer interface prevented mVP40 assembly, budding of VLPs,
and greatly reduced anionic membrane binding (11). The key
residues involved in NTD oligomerization in eVP40 hexamers
were also found to align in sequence and structure with mVP40,
Trp83 andAsn148, respectively.Mutation of this Trp andAsn in
mVP40 greatly reducedVLPbudding (11). TheCTDofmV40 is
significantly different from eVP40. The basic patch of mVP40
features a flatter andmore extended surface than that of eVP40,
and consists of basic amino acids Lys210, Lys211, Arg215, Lys218,
Lys259, Lys264, Lys265, and Arg266. Mutations of basic patch res-
idues abrogated mVP40 assembly and greatly reduced VLP
budding (11). The significant reduction in assembly is most
likely due to the significant reduction in anionic lipid binding by
these mutations (11). We have previously investigated mem-
brane binding properties of mVP40 and found that consistent
with the structural features of the mVP40 basic patch, mVP40
associates with the plasma membrane via nonspecific electro-
statics highly dependent on the anionic charge density of the
membrane (17). However, the consequences of lipid binding on
mVP40 assembly and structural transitions is still unknown.
To investigate the origins of phosphatidylserine (PS) or
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) binding and
structural consequences of PS or PI(4,5)P2 binding by mVP40,
we have used hydrogen/deuterium exchange mass spectros-
copy (HDX-MS) tomeasure the deuteration level of themVP40
amino acid sequence with and without lipids. HDX-MS has
been previously used to investigate protein structure, confor-
mational changes, and dynamics of ligand binding (18–20).
HDX-MS has also been successfully used to investigate struc-
tural changes occurring on peripheral membrane proteins that
interact with cell membranes (21, 22). Results reported herein
demonstrate robust coverage of the mVP40 sequence with
respect to deuterium exchange and reveals the primary sites of
PS and PI(4,5)P2 binding and structural transitions necessary to
expose the conserved NTD interface involved in mVP40 oligo-
merization. Lipid binding assays, molecular dynamics (MD)
simulations, andmembrane insertionmeasurementswere used
to complement the HDX-MS work and elucidate the mecha-
nism by which mVP40 associates with the plasma membrane.
Results
mVP40 coveragemap of pepsin fragmentation
To determine the optimumdigestion conditions that yielded
the best peptide fragmentation pattern for mVP40, changes in
the denaturant (GdnHCl) concentration (0, 0.08, 0.8, 1.6, 3.2,
Figure 1. Peptide coverage map of mVP40. Pepsin digestion produced 77 unique overlapping peptides that resulted in 99% coverage of the mVP40
sequence.
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and 6.4 M) were employed. The most significant coverage of
unique peptides was found at 0.8 M GdnHCl (final concentra-
tion inHDexchange sample 0.5M), where 77 unique peptides
were selected and analyzed for the data generation. (The cov-
erage map for these 77 peptides is shown in Fig. 1.)
Deuterium on-exchange ofmVP40 in solution
The percentage of hydrogen-deuterium exchange for each
unique peptide used in the analysis was determined at five dif-
ferent time points (10, 100, 1000, 10,000, and 100,000 s) and is
depicted in the ribbonmap ofmVP40 (Fig. 2,A andB). The first
14 residues at the N terminus are part of the His tag sequence
used in mVP40 purification and exhibited significant deutera-
tion likely due to their accessibility to the solvent. Note that
these residues are not shown in the structural figures as they
were not resolved in the X-ray crystal structure. The first 38
residues of the NTD of mVP40 are also highly flexible and did
not appear in the crystal structure of the protein. The deute-
rium incorporation to these residues (as well as the aforemen-
tioned His tag) was more than 90% even at the 10-s exchange
period (Fig. 2A). Residues from 40 to 52 of the 1 strand of
mVP40 are part of the NTD-NTD dimer interface (see Fig. 2B)
Figure 2.Hydrogen deuterium exchange of mVP40 in the absence of lipid vesicles. A, ribbon map indicating the percentage of hydrogen/deuterium
exchange that occurred in peptide fragments over the entire exchange period. Each row corresponds to each time point from 10 to 100,000 s. Color coding
indicates the percentage of deuterium incorporation at the given time point. B, percent labeling of the 10-s time point wasmapped onto the crystal structure
of mVP40 (PDB code 5B0V).
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(11) and at the 10-s exchange time period deuterium incorpo-
ration was very low (10% deuteration level). This is consistent
with the crystal structure ofmVP40,which elucidated three direct
H-bonds that occur across the dimeric interface between Thr40
and Asn42, Thr40 and Tyr43, and between Asn42 and Asn42 of the
opposingmonomers (11). These close contacts andH-bondsmay
limit solvent accessibility to this region lowering the deuterium
accumulation as shown in Fig. 2. As the HD exchange time
increases, the amount of deuterium incorporated also increases.
This suggests the region of the 1 strand is dynamic and may
undergo structural fluctuations over prolonged time periods,
which facilitate exposure of amide hydrogens of that region.
The 1 helix, mVP40 residues Ala97-Thr105 (see Fig. 2,A and
B) are also a part of the dimer interface (11) and demonstrated
slowHDexchange levels throughout the exchange time periods
analyzed. The residues of 1 helical dimer interface exchanged
much more slowly even at prolonged exchange time periods
when compared with residues from the 1 strand (residues
40–52) (Fig. 2, A and B). The 1 helices form multiple hydro-
phobic contact points and therefore largely excludewater. Also,
the  helical structures have most of their amide hydrogens
involved in internal hydrogen bonding interactions, which can
slow HD exchange rates. As a result of impaired solvent acces-
sibility to this region and slow HD exchange rates, deuterium
accumulation in this region is very low.
The CTD of mVP40 contains a broad basic patch, which has
been shown to mediate membrane binding to anionic lipids
such as phosphatidylserine (17). The basic patch primarily con-
sists of two basic loops where the first basic loop (Thr208-
Asn222, Fig. 2, A and B) harbored about 70–80% deuterium
incorporation level at the 10-s exchange period and90% deute-
rium incorporation at the 100-s time point and beyond. These
residues are solvent exposed in the crystal structure and their
amide hydrogens are not part of secondary structures and not
extensivelyH-bonded.Therefore, residuesof this basic loop, in the
absence of membranes, exhibit90% deuterium incorporation.
The second basic loop of the CTD spans from Leu251 to
Pro271 (Fig. 2, A and B) (11). However, at the 10-s exchange
period this region exhibited 50% deuterium incorporation and
took10,000 s to reach considerable deuteration levels unlike
the first basic loop (Fig. 2, A and B). In the crystal structure of
mVP40, the short disordered loop that contains residues Lys264,
Lys265, and Lys266 was not resolved (delineated by * in Fig. 2B).
It was surprising to observe that this disordered loop, which
lacks secondary structure and is likely to be solvent exposed
exhibited slower deuterium incorporation levels. However, it is
possible that although disordered, the amide hydrogens of this
region participate in internal H-bonding producing slower
exchange rates. Indeed, MD simulations of the mVP40 protein
demonstrated that basic residues in this loop are involved in
intermolecular interactions, which may limit exchange with
deuterium (see more discussion below).
An interesting observation was made regarding the
61FTLEA65 sequence (Fig. 2, A and B) of the 2 strand of
mVP40. This region showed very low levels of deuterium incor-
poration (10%) even at the longest time point (100,000 s) of
HD exchange (Fig. 2, A and B). The 2 strand forms an antipa-
rallel  sheet with the 3 and 7 strands and due to strong
H-bondnetworks in antiparallel sheets, we can expect theHD
exchange rates to be low. Also, its location between  strands
causes this region to be buried inside the mVP40 NTD, mini-
mizing its solvent accessibility. As a result, even after a pro-
longed period of incubation with D2O, deuterium incorpo-
ration did not significantly occur in this region. Thus, we
hypothesize if mutations were to occur in the 2 strand that
increased the flexibility or hydrophilicity of this region, it would
most likely destabilize the NTD.
Effects of phospholipidmembrane interaction onmVP40
basic loops
To resolve the effects of phosphatidylserine binding on
mVP40 structural dynamics, HD exchange experiments were
done on mVP40 following preincubation with phospholipid
vesicles. We hypothesized this approach could confirm the
mVP40 membrane binding surface that has been previously
established (11, 17) and elucidate structural transitions, reveal-
ing sites of mVP40 oligomerization that occur during viral
matrix assembly. We employed lipid vesicles that were com-
posed of POPC:POPS (55:45) as a model phospholipid mem-
brane as previously employed in mVP40 lipid binding assays
(17). mVP40 exhibits saturation levels of membrane binding in
the presence of40mol%POPS (17). By providing an excess of
anionic phospholipids at 45 mol % POPS, we are ensuring
mVP40 is achieving its saturation level of binding. Exchange
experiments were carried out at five different time points from
10 to 100,000 s to directly compare deuterium incorporation of
mVP40 incubated in solutions without lipids.
To obtain peptide specific HD exchange information, deute-
rium accumulation plots for both mVP40 alone and mVP40 in
the presence of POPC/POPS vesicleswere generated. Examples
of such deuterium accumulation plots are shown in Fig. 3. We
first looked at the differences in deuterium incorporation in
the basic patch region of mVP40 in the presence of liposomes
compared with the protein alone sample.
In the presence of PS containing liposomes, basic loop 1
(208–222) exhibited a reduction in deuterium incorporation
into the peptide backbone compared with protein alone at 10-
and 100-s time points. However, as longer incubation times
were analyzed a similar level of deuterium incorporation was
observed for mVP40 with and without PS. Because basic loop 1
of mVP40 associates with the PS containing membranes (11),
the basic patch is likely shielded from the bulk solvent bymem-
branes, causing reduced deuterium incorporation. However,
the interaction of mVP40 with PS containing membranes is
likely to be very dynamic with continuous association and dis-
sociation events occurring facilitating deuterium exchange to
occur with the bulk solution when mVP40 transiently dissociates
from themembrane. As a result, at longer periods of D2O incuba-
tion, more deuterium may get incorporated to the basic patch 1
region. Basic patch 2 (251–271) exhibited a similar trend as basic
patch 1 at short incubation times with PS containing vesicles (10 s
and 100 s), although to begin with the level of deuterium incorpo-
ration in the absence of liposomes was moderate (50%).
In an attempt to further understand the observed differences
in deuteration pattern between basic loop 1 and basic loop 2,
which can equally cause strong disruptions in proteins ability to
HDX-MS analysis of VP40 lipid binding
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bind to membranes as well as form VLPs in cells (11) we used
MD simulations to model interactions of the mVP40 basic patch
with a phospholipidmembrane. Residues that were absent on the
crystal structure of protein, including the missing basic loop resi-
dues canbemodeled into the in silico systemallowingus to extract
useful information on its location on the surface of the protein as
well as its membrane interactions (Fig. 4).
Fig. 4A shows the initial structure of the mVP40 dimer, with
basic loop 1 and basic loop 2 highlighted in surface representa-
tions.During theMDsimulationof themVP40-membranesystem
we were able to observe the mVP40 basic patch interacting with
themembrane.Fig. 4B showsa snapshotof theprotein-membrane
system at 100 ns of theMD trajectory.We evaluated the flexibility
of the residues composing the basic patch in the presence and
absence of the membrane system by calculating the root mean
square fluctuations, as shown in Fig. 4C. The CTD segments that
included basic loop 1 and basic loop 2 exhibited significantly
reduced fluctuations when they interact with the membrane (Fig.
4C). Also the degree of reductionwe observe for both basic loop 1
residues and basic loop 2 residues are similar in magnitude sug-
gesting both of these loops are engaging with the membrane in
similar intensities. Indeed, quantitative assessment of binding to
lipid vesicles using surface plasmon resonance (SPR) demon-
stratedmutationof basic loop 1or basic loop 2 greatly reduced the
ability ofmVP40 to associate with liposomes containing 40mol %
PS or 7.5 mol % PI(4,5)P2 (Fig. 5,A and B).
Interestingly, basic loop 2 residues displayed a slower ex-
change rate with deuterium than basic loop 1 residues (Fig. 2A)
in the absence of lipids. This suggests basic loop 2may undergo
more significant intramolecular interactions prior to engaging
the lipid membrane, which would shield amide hydrogens and
slow the exchange. MD simulations revealed that several resi-
dues in basic patch 2 engaged in intramolecular h-bonds. This
included the Lys264 side chain with the Gly261 backbone, the
Lys264 side chain with the Lys259 backbone, the Lys265 side
chain with the side chain of Asp177, the Lys265 backbonewith the
backbone of Val258, and the Arg266 side chain interacting with
the Asp177 side chain and backbone of Met263. Throughout the
MDsimulations, basic loop 2 residues increased h-bondswith lip-
ids while also maintaining intramolecular h-bonds for an average
of6 h-bonds for basic loop 2 residues throughout the trajectory
(Fig. 4D). The major interactions of basic loop 2 with the mem-
brane included the side chain of Lys264 and PS, the side chain of
Lys265 and PS, and the side chain of Arg266 and PI.
Figure 3. Deuterium accumulation plots generated formVP40 alone andmVP40 in the presence of lipid vesicles.Deuterium level at each time point is
plotted for mVP40 alone (dark blue line), mVP40 lipid vesicles (orange line) for each unique peptide identified using DXMS explorer software.
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Effects of phospholipidmembrane interaction onmVP40 NTD
dimer interface
Deuteriumaccumulation levels in the1helix (97–105) and the
1 strand that composed the dimer interface of themVP40 dimer
showed no significant differences in the presence and absence
liposomes (Fig. 3). Under both conditions HD exchange was low,
resulting in low deuterium incorporation suggesting this region
has been largely inaccessible to bulk solvent. Because the deute-
rium accumulation levels were unchanged formVP40 in the pres-
ence of liposomes, strongly suggesting that the dimer does not
dissociate into monomers upon membrane association and/or
dissociationand thedimer is likely tobe thebuildingblockofother
oligomeric forms of mVP40.
The 61FTLEA65 sequence of the2 strand ofmVP40 that was
solvent inaccessible in the absence of liposomes also showed
no change in deuteration levels in the presence of liposomes.
Therefore, it is unlikely that the anti-parallel  sheet it forms
with 3 and 7 strands does become more solvent exposed
duringmVP40membrane interactions or oligomerization trig-
gered during matrix assembly.
HDX-MS ofmVP40 reveals potential oligomerization
interfaces
Some of the deuterium accumulation plots of peptide frag-
ments showed significant changes in the deuteration levels in
the presence of phospholipid membranes compared with the
protein alone sample (Fig. 6). These peptide fragments do not
originate from the dimer interface or basic patch ofmVP40 and
hence we hypothesize that these peptides arise from regions of
mVP40 that undergo structural changes triggered by mVP40
interaction with phospholipid membranes. For further analysis
of these regions we produced a rainbow map for mVP40 in the
presence of membranes representing the percentage of hydro-
gen/deuterium exchange for each overlapping peptide for the
entire length of reaction (Fig. 7A).
Compared with the mVP40 protein sample without lipids,
the HD exchange pattern of mVP40 in the presence of PS differ
considerably. Overall, in the presence of PS, mVP40 exhibited
slower HD exchange rates than that of protein alone sample
indicating significant regions of less solvent accessibility (Fig. 7,
A–C). The reduction of HD exchange levels in the basic patch
region of mVP40 was anticipated because membrane binding
would shield the previously solvent-exposed surface. However,
the reduction of HD exchange levels were not limited to the
basic patch regions, signaling that association of phospholipid
membrane at the C-terminal basic patch triggers other struc-
tural changes onmVP40. If the protein undergoes oligomeriza-
tion and forms filamentous structures, the oligomerization
sites would become solvent inaccessible. Also, if the filamen-
tous structures further assemble to form the viral matrix it will
Figure 4. Modeling mVP40 interaction with the plasma membrane. A, structure of the mVP40 dimer following modeling of missing residues from the
crystal structure into the in silico system. The basic loop 1 is highlighted in blue andbasic loop 2 is in green. B, mVP40 dimer associated at the lower leaflet of the
plasmamembrane (snapshot after 100 ns of MD simulation). C, root mean square fluctuations (RMSF) for the CTD segment containing residues in basic loop 1
and basic loop 2. Blue is mVP40without lipid and red is mVP40 in the presence of themembrane bilayer.D, the number of hydrogen bonds (h-bonds) for loop
2 residues (Lys264, Lys265, and Arg266) (blue, mVP40 protein-protein h-bonds; red, mVP40 h-bonds with lipid) as a function of time (moving average, averaged
every 100 ps). Initially, these residues make more h-bonds with protein but later make about the same with protein and lipids. On average,6 h-bonds are
made at all times (3 with other amino acids, 3 with lipids).
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cause greater shielding of individual mVP40 dimers lowering
HD exchange levels.
Alternatively, lowHDexchange levels in the presence of lipo-
somes may also result if the protein can penetrate the mem-
brane forming hydrophobic interactions with the lipid acyl
chains of the membrane. This can result in reduced solvent
accessibility of the protein domain that penetrates into the
membrane. To ensure the observed reduction in HD exchange
levels of mVP40 in the presence of negatively charged lipo-
somes is not due to protein insertion into themembranewe did
monolayer insertion experiments (Fig. 5, C and D). Maximum
insertion pressure (MIP) of the protein that can be derived from
these experiment is useful to determine whether the protein
can insert into themembrane at a given lipid composition.MIP
values below 30 mN/m suggests the protein does not penetrate
into the hydrocarbon region of the phospholipid membrane
(23). We measured the change in surface pressure induced by
mVP40 on lipid monolayers composed of 0, 20, or 30mol % PS,
however, the MIP values derived from these experiments did
not exceed30mN/m.This confirmed thatmVP40doesnot signif-
icantly penetrate into PS containing membranes. Hence, this fur-
ther supports the hypothesis that regions of mVP40 exhibiting
significant reductions in deuteration levels (excluding the basic
patches and dimer interface) are most likely due to membrane
triggered structural changes including oligomerization inmVP40.
By comparing ribbon maps generated for mVP40 protein
alone sample and mVP40 preincubated with PS containing
membranes, the change in the deuteration percentage (%D) of
mVP40 for the entire length of the experiment was mapped
(Fig. 8). This data provides a clear overview of the regions of the
mVP40 protein that have shown significant differences in the
deuteration level in response to the presence of PS. We identi-
fied locations of the peptide sequences that showed significant
changes in deuteration by mapping them to the crystal struc-
ture of mVP40 (Fig. 9). Among the peptide fragments that
showed significant changes in deuteration were Ile66 to Gly87,
Thr109 to Phe120, Phe160 to Leu167, the basic loop 1 region
(Thr208-Asn222), and Gly223 to Leu235 (the 4 helix) (Fig. 9A).
Basic loop 1 (Thr208-Asn222) undergoes significant reduction
in deuterium levels as it interacts with anionic membranes as a
result of reduced solvent exposure of this region. Interestingly,
we also find that the 4 helix located beneath the basic loop 1
also harbors significant reduction in deuteration levels. The
sequence of 4 helix shows hydrophobic character and we
hypothesize the loss of accessibility of the solventmay be due to
assembly ofmVP40 dimers in an end to endmanner to form the
hexamer, which further assembles into filamentous structures.
Notably, a similar mechanism of filament assembly was re-
cently proposed for eVP40 (12).
An alternative explanation to the observed changes in deu-
teration levels in the 4 helix is that during interaction of
mVP40 with the membrane, the 4 helix gets shielded by the
basic loop 1 as the loop adjust its position to form electrostatic
interactions with the membrane. MD simulations of mVP40 in
Figure 5.mVP40 SPR lipid binding andmonolayer penetration assays. A and B, comparison of phospholipid binding ability of two basic patchmutants to
wild type mVP40. R215A/K218A is a basic loop 1 mutant and K264A/K265A/R266A is a basic loop 2 mutant. SPR sensograms are shown for 500 nM wild type
mVP40 (black), R215A/K218A (blue), K264A/K265A/R266A (green) for:A,POPC:POPS (60:40);B, PC:PI(4,5)P2 (92.5:7.5) liposomes. Bothmutants exhibit significant
reduction in vesicle interaction for both lipid compositions in comparison to wild type mVP40. C–E, change in surface pressure versus initial lipid monolayer
surface pressure is plotted following interaction withmVP40. Phospholipid compositions tested for mVP40 insertion are shown above each graph. MIP values
are obtained by extrapolating to the x axis (x intercept). MIP values for PS containing monolayers were below 30 mN/m.
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the presence of membrane show that as the basic loop 1 inter-
acts with the anionic membrane surface, it slightly envelops
part of the 4 helix below loop 1 (Fig. 10A). The solvent acces-
sible surface area of the 4 helix shows a slight decrease after
about 50 ns of MD trajectory (Fig. 10B). This may also explain
why lower deuteration levels were observed for the 4 helix
apart from an oligomerization event.
HDX-MS ofmVP40 in the presence of zwitterionicmembranes
and PI(4,5)P2 containingmembranes
We broadened our investigation of the engagement of basic
patch residues of mV40 with phospholipid membranes by
experimenting on how mVP40 interacted with membranes
devoid of anionic lipid (POPC zwitterionic lipid) as well as
membranes containing another important anionic plasma
membrane lipid, PI(4,5)P2.
We have previously shown mVP40 to be an anionic charge
sensor that exclusively interacts with negatively charged lipids
(17). We have hypothesized that for the structural changes in
mVP40 necessary for oligomerization to occur, the mVP40
dimermust first form interactions with the phospholipidmem-
brane. Therefore, we performed several other HDX-MS exper-
iments where we preincubated mVP40 protein with lipid vesi-
cles that were composed entirely of zwitterionic phospholipid/
phosphatidylcholine. In the absence of an anionic membrane
surface, mVP40 cannot form significant electrostatic interac-
tions with membranes and hence does not bind zwitterionic
membranes at nanomolar or micromolar concentrations (17).
In support of the central hypothesis, the HDX pattern of
mVP40 protein alone andmVP40 in the presence of PC vesicles
looked very similar at 10- and 100-s time points, indicating the
protein exhibited no significant changes in the solvent accessi-
bility in the presence of PC liposomes (Figs. 11 and 12A). This
is in stark contrast to the HDX-MS pattern observed when
mVP40 was preincubated with PI(4,5)P2 or PS vesicles, which
caused significant reduction in solvent accessibility (Fig. 13B).
We also observed that at the 1000-s time point, mVP40 exhib-
ited higher deuterium incorporation compared with the pro-
tein alone sample suggesting an increase in the solvent accessi-
bility of the protein in the presence of neutral phospholipid
membrane (Figs. 11B and 12B). This can be a result of nonspe-
cific zwitterionic interactions causing the mVP40 protein to
slightly deform its structure making some regions more acces-
sible to solvent than in the absence of PC. However, further
studies are necessary to understand this occurrence and its sig-
nificance including more HDX-MS data at longer time points
(10,000 s and 100,000 s) especially to see if the trend continues.
Next, we investigated the effect of having another anionic
phospholipid in the membranes on mVP40 solvent accessibil-
ity. PI(4,5)P2 is another anionic phospholipid that is found at
the inner leaflet of the plasmamembrane and plays a significant
role in recruitment of peripheral proteins to the plasma mem-
brane surface (24). PI(4,5)P2 harbors a net negative charge
of4 at pH 7.4 (25). From our previous findings, we know that
mVP40 exhibited saturation binding when the membranes
Figure 6. Effects of phospholipidmembranes on theHDexchangepattern ofmVP40.Deuteriumaccumulation plots of peptide fragments ofmVP40 that
showed significant differences in the deuterium levels in the presence and absence of liposomes. Deuterium levels of mVP40 alone in the absence of lipid
vesicles is shown in light blue line; VP40L denotes mVP40 in the presence of PS containing lipid vesicles (orange line).
HDX-MS analysis of VP40 lipid binding
APRIL 14, 2017•VOLUME 292•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 6115
contained 7.5% (mol %) of PI(4,5)P2 (17). We also tested a lipid
composition that contained 20% (mol %) of PS and 5% (mol %)
PI(4,5)P2 to observe the combined effects on mVP40 of two
different types of anionic phospholipids in themembrane. This
composition also previously facilitated saturation binding of
mVP40 to phospholipid membranes (17). For both membrane
compositions, the changes in the deuteration labeling of the
protein looked very similar to each other and to the labeling
pattern of mVP40 in the presence of 45% (mol %) PS (Fig. 13, A
and B). The changes in the deuteration percentage for the basic
patch residues looked very similar under all conditions with the
exception of more deuterium incorporation in basic loop 1 for
PI(4,5)P2 compared with PS or PS  PI(4,5)P2 (Fig. 13). This
confirmed the lack of specific binding pockets on the mVP40
surface that promote stereospecific interaction among specific
anionic phospholipid head groups further confirming mVP40
exhibits nonspecific interactions with anionic phospholipids as
an electrostatic charge sensor.
Discussion
Themajority of deuteration level changes triggered bymem-
brane association were detected in the NTD of mVP40 (Fig. 8, A
and B). This included regions spanning from the end of the 2
strand to the end of3 strand (Ile66-Gly87), the entire4 strand,
and the beginning of 5 strand (Thr109 to Phe120 includes), as
well as the 7 strand (Phe160-Leu167). The NTD of eVP40 was
particularly important in oligomerization of rearranged hex-
amers following eVP40 conformational changes induced by a
membranemimetic as described previously (12).2,3, and7
strands together form an antiparallel  sheet structure and we
found the concentrationof twomajor deuteration level changes in
this region is intriguing.Wehypothesize that this sheet structure
provides anoligomerization interface for themVP40NTDfollow-
ing associationwithPScontainingmembranes.This is basedupon
the aforementioned HD exchange data but also the homology of
this region inmVP40 to that of eVP40.
The structural transition of the eVP40 NTDwould make the
previously buried Trp95 residue, which forms the core of the
oligomerization surface of eVP40, more accessible to protein-
protein interactions. Sequence alignment between eVP40 and
mVP40 reveals that Trp83 of mVP40 aligns with the Trp95 of
eVP40 (12). Trp83 residue is present in the 3 strand that un-
dergoes significant reduction in solvent accessibility. There-
fore, it is possible to suspect this 2, 3, and 7 antiparallel 
sheet structure provides an oligomerization surface for matrix
assembly. The 5 strand is also likely to be part of the same
oligomerization surface as it also extends in the same direction
Figure 7. Hydrogen/deuterium exchange of mVP40 in the presence of PS containing vesicles. A, ribbon map indicating the percentage of hydrogen/
deuteriumexchange that occurred in peptide fragments over the entire exchangeperiod. Each row corresponds to each timepoint from10 to 100,000 s. Color
coding indicates the percentage of deuterium incorporation in the given time point. B, percent labeling of the 10-s time point mapped onto the crystal
structure of mVP40 (PDB code 5B0V). Color coding is as indicated in A. C, space fillingmodels of mVP40 protein (right) andmVP40 after incubation with lipids.
Side view of a mVP40 monomer is also shown for both conditions.
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as the 2, 3, and 7 antiparallel  sheet structure. Moreover,
three other mVP40 residues have been shown to be conserved
with the eVP40 NTD oligomerization interface including
Arg136, Arg139, and Asn148. In the case of Asn148, a significant
reduction in deuteration level following incubation with PS
containing membranes was detected (Figs. 7–9).
To the best of our knowledge, this is the first structural study
done on mVP40 using HDX-MS. Here we have optimized
conditions to get robust coverage of deuteriumexchange on the
mVP40 amino acid sequence, which has identified structural
changes triggered by mVP40 interaction with anionic mem-
branes. In Fig. 14we propose amodel ofmVP40 assembly in the
presence of PS containingmembranes. Here, themVP40 dimer
associates with PS containing membranes with basic patches
enriched with several cationic residues (Lys210, Lys211, Arg215,
and Lys218 in basic loop 1; Lys264, Lys265, and Arg266 in basic
loop 2), mutation of which previously abrogated anionic lipid
binding, plasma membrane localization, and virus-like particle
formation (11). Quantitative bindingmeasurements performed
in this study confirmed the important roles of basic patch 1 and
2wheremutations of these patches associatedweakly at nanomo-
lar concentrations compared with wt mVP40. MD simulations
further providedmolecular insight demonstrating both basic loop
1 and 2 engage the anionic membrane surface with electrostatic
and h-bonds throughout the trajectory time.
Following association with the anionic membrane interface,
mVP40 oligomerizes through a NTD interface that was par-
tially buried and solvent inaccessible in the absence of PS. VP40
oligomers are also likely to oligomerize through the 4 helix in
the CTD in a similar manner to CTD end-to-end contacts pre-
viously shown for eVP40 (12). Although this helix does tilt
toward themembrane interface, reducing its solvent accessibility,
themodestdecrease insolventaccessibilityuncoveredbyMDsim-
ulationswasnot as significant as thedrastic changes to this helix in
deuterium incorporation in the presence of anionic membranes.
Strikingly, mVP40 membrane penetration in the presence of
PS containing membranes was significantly less than that pre-
viously found for eVP40 (14, 26). Hydrophobic interactions
were found to be a critical component of eVP40 assemblywhere
PS-dependentmembrane penetration of eVP40was essential to
eVP40 oligomerization and formation of VLPs (14, 26). mVP40
instead seems to rely on a dense cationic CTD surface andmul-
tiple interactions with the anionic membrane surface (17) to
effectively assemble and oligomerize. This further underscores
the differential lipid binding mechanisms that have been
proposed for mVP40 and eVP40 (11, 12, 15, 17, 27, 28), which
Figure 8. InfluenceofmembraneassociationonmVP40as ameasureof the change indeuteration level (D%) in comparison tomVP40 in the absence
of liposomes. A, difference in deuteration percentage of mVP40 in the presence of liposomes wasmapped to the sequence over the entire exchange period.
Each row corresponds to each time point from 10 to 100,000 s. Color coding: blue indicates the regions that exchange slower in the presence of lipid and red
indicates the regions that exchange faster in the presence of lipid. B, differences in deuteration level (D%) in the presence of liposomes of the 10-s time point
mapped on to the crystal structure of the mVP40 (PDB code 5B0V).
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harbor membrane binding CTDs of modest sequence identity
(16% identical). In closing, HDX-MS combined with in vitro
biochemistry and cellular studies should be an excellent tool to
further reveal assembly properties of filovirus matrix proteins.
Experimental procedures
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS),
1,2-dioleoyl-sn-glycero-3-phospho-, and 1-myo-inositol 4,5-
bisphosphate (PI(4,5)P2) were purchased from Avanti Polar
Lipids (Alabaster, AL) and used without further purification.
D2O was obtained from (Cambridge Isotope Laboratories Inc.,
Tewksbury, MA). Formic acid and GdnHCl were purchased
from (Fisher Scientific).
Protein expression and purification
mVP40 protein harboring a His6 tag was expressed and puri-
fied as described by Wijesinghe et al. (17).
Optimization of peptide digestion
Before deuterium-labeling experiments were performed,
optimumdigestion conditions that provide a optimumpeptide
fragmentation pattern with overlapping peptides that produce
the maximum coverage the entire length of protein had to be
selected (24). Various digestion conditions were tested by vary-
ing the concentration of GdnHCl (0, 0.08, 0.8, 1.6, 3.2, and 6.4
M) in quenching buffer that also contained 0.8% (v/v) formic
acid at pH 2.3 and 16.6% (v/v) glycerol. 3g of protein was used
in each experiment. Quenching experiments were carried out
as described under “Deuterium Exchange Experiments.”
Figure 9. Regions of mVP40 that have undergone significant changes in deuteration percentage (D%) triggered by PS-dependentmembrane asso-
ciation. A, major D% changes mapped to the mVP40 crystal structure. In blue, Ile66-Gly87; purple, Phe160-Leu167; green, Thr109-Phe120; red, Thr208-Asn222; teal,
Gly223-Leu235. B, space filling model of mVP40 at the 10-s time point showing regions on the mVP40 structure that has shown significant changes in the D%.
Single arrows indicate the 4 helix, which may provide CTD-CTD oligomerization surface. Double arrows indicate a potential oligomerization interface at the
NTD that gets exposed following structural rearrangement ofmVP40 followingmembrane association. C, residues Leu226, Ser229 of the4 helix in the CTD and
W83 in the NTDmay mediate key interactions during oligomerization.
Figure 10. Conformational rearrangement of basic loop 1 (residues 208–221) due to membrane interactions. A, as basic loop 1 interacts with the
membrane, thegapbetween the-helix below loop1 is slightly reduced.B, change in the solvent accessible surface areaof4helix residues (223 to 231) along
the MD trajectory. At the end of 100 ns of MD simulation, the solvent accessible surface area of the 4 helix was reduced.
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Figure 12. Influence of presence of zwitterionic phospholipid membranes on mVP40 as a measure of the change in deuteration level (D%) in
comparison tomVP40 in the absence of zwitterionic membranes. A, percent deuterium labeling of mVP40 in the presence and absence of PC vesicles for
the 10-s time pointmapped on to the crystal structure of themVP40 (PDB code 5B0V). B, difference in deuteration percentage ofmVP40 in the presence of PC
liposomes ismapped to the sequence over the entire exchangeperiod. Each row corresponds to each timepoint from10 to 1000 s. Color coding: blue suggests
the regions that exchange slower in the presence of PC vesicles; and red suggests the regions that exchange faster in the presence of PC vesicles.
Figure11.Hydrogen/deuteriumexchangeofmVP40 in thepresenceandabsenceof zwitterionic lipidvesicles.A, ribbonmap indicating thepercentage
of hydrogen/deuterium exchange that occurred in peptide fragments over the entire exchange period for the protein alone sample. B, ribbonmap indicating
the percentage of hydrogen/deuterium exchange that occurred in peptide fragments over the entire exchange period for the protein preincubated with PC
vesicles. Each row corresponds to each timepoint from10 to 1000 s. Color coding indicates the percentage of deuterium incorporation in the given timepoint.
Residue numbering begins after the first 14 amino acids that compromise the His tag. B, percent labeling of the 10-s time point mapped on to the crystal
structure of the mVP40 (PDB code 5B0V).
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Preparation ofmultilamellar vesicles (MLVs)
For the preparation of PS containing liposomes, POPS and
POPCweremixed in the ratio of 45:55, respectively, to form the
MLVs. PI(4,5)P2 containing liposomes were prepared by mix-
ing POPC and PI(4,5)P2 in a 92.5:7.5 molar ratio, whereas com-
bined PS:PI(4,5)P2 MLVs were prepared by mixing POPC,
POPS, and PI(4,5)P2 at 75:20:5 molar ratio. Briefly, lipids were
mixed in the indicatedmolar ratio and dried underN2 gas for 10
min. The dried lipid film was hydrated using dH2O at 65 °C for
15 min. Following hydration, the lipid film was vortexed vigor-
ously to form MLVs (17, 29). For on exchange experiments, 3
g of protein was incubated with excess MLVs for 20 min at
room temperature. Final lipid concentration was 2.8 mM and
final volumewas 6l. For protein alone samples, 3g of protein
was diluted in dH2O.
Deuterium exchange experiments
HDX experiments were initiated by mixing 18 l of D2O
buffer (8.3 mMTris, pH 7.2, containing 150mMNaCl) into 6-l
samples at pH 7.2. Following addition of D2O buffer, samples
Figure 13. mVP40 interaction with PI(4,5)P2 containing vesicles results in a similar hydrogen/deuterium exchange pattern compared with PS con-
taining vesicles. A, space filling models of mVP40 protein after preincubation with PI(4,5)P2 vesicles (right) and PS PI(4,5)P2 combined vesicles (left). Side
view of a mVP40 monomer is also shown for both conditions. B, difference in deuteration percentage of mVP40 mapped to the sequence over the 10-s
exchangeperiod for all lipid compositions tested. Color coding: blue suggests the regions that exchange slower in the presence of liposomes; and red suggests
the regions that exchange faster in the presence of liposomes.
Figure 14. Hypothesized oligomerization pathways ofmVP40 that leads to viralmatrix assembly inside an infected host cell. CytosolicmVP40 dimers
associate with the inner leaflet of the plasma membrane by interacting with anionic phospholipids such as phosphatidylserine. mVP40 dimers further
oligomerize on the membrane surface by interacting via the CTD in an end-to-end manner to form a linear hexamer. Matrix assembly may occur through
further oligomerization of linear hexamers with another hexamer unit by interacting via the NTD of composing dimers that facilitate the formation of linear
filaments. Alternatively, the linear hexamer may be an intermediate that undergoes structural rearrangement similar to the eVP40 protein. The rearranged
hexamer may then assemble into the matrix layer via NTD interactions.
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were incubated 10, 100, 1000, 10,000, and 100,000 s at 4 °C. The
deuterium exchange was quenched at 0 °C for 1 min by the
addition of 6 l of optimized quenching buffer (0.8% formic
acid, 2.5 M GdnHCl, 0.6 MNaH2PO4, and 50% glycerol, pH 2.4).
The control samples for correcting back exchange were also
prepared as previously described (25). The samples were then
immediately frozen on dry ice and stored at 80 °C until used
in mass spectrometry analysis.
Pepsin digestion and LC-MS analysis of samples
Pepsin digestion and LC-MS analysis was done as described
previously (30, 31). Briefly, frozen samples were loaded onto a
cryogenic autosampler and then were thawed for 60 s at 5 °C
before being loaded onto an immobilized pepsin column (16-l
bed volume) at a flow rate of 20 l/min to allow digestion of
proteins. Pepsin-generated peptide fragments were collected
on aC18 trap column (0.2 1mm,OptimizeTech Inc.,Oregon
City, OR) for desalting, and flowed through a reverse phase
C18 column (0.2 50mm,MAC-MODAnalytical Inc., Chadds
Ford, PA) for fragment separation using a linear acetonitrile gra-
dient (6.4–38.4%) over 30 min. The eluent was directed into the
OrbiTrap Elite mass spectrometer (Thermo Fisher Scientific) for
MS analysis. Peptide identification was done by using Proteome
Discoverer software (Thermo Fisher Scientific) (30, 31).
Deuterium quantification and data analysis
The centroid values of all the deuterated peptides were cal-
culated with DXMS Explorer (Sierra Analytics Inc., Modesto,
CA), and then converted to the amount of deuterium incorpo-
ration with corrections for back-exchange (26). All HDX data
were normalized to 100% D2O content with an estimated aver-
age deuterium recovery of 75%. The deuterium incorporation
within the sequence of VP40 was further sublocalized with an in-
house MATLAB program using the difference between overlap-
ping peptides as previously described (27). The standard deviation
of HDXmeasurements performed on our system is normally less
than 2% of the mean of triplicate experiments (28).
Molecular dynamics simulations onmVP40membrane
interactions
The mVP40 structure was obtained from the Protein Data
Bank (PDB code 5B0V) and the missing residues were added
with Modeler (32). The protein and plasma membrane system
was built using Charmm-GUImembrane builder web interface
(33). The asymmetric lipid bilayer was generated with the lipid
distributions of POPC, POPE, POPS, POPI, sphingomyelin
(PSM), and cholesterol comparable with the known plasma
membrane composition (34, 35). The composition of different
lipid molecules in the lower leaflet of the plasma membrane
were in the ratio of 11:33:18:9:7:20 (POPC:POPE:POPS:POPI:
PSM:cholesterol) and the resulting membrane contained 574 lip-
ids. The membrane-protein systemwas solvated with TIP3 water
in cubic boxes and neutralized with 0.15 MKCl. The final solvated
systemcontainedmore than 200,000 atoms.A separate system for
the mVP40 dimer was set up without the membrane that also
containedmore than 200,000 atoms.
All-atom MD simulations were performed with CHARMM36
force field (36) usingNAMD2.11 (37). The particlemesh Ewald
method (38) was used to calculate the long range ionic interac-
tions. For each system, a 10,000-step minimization was per-
formed followed by equilibration runs. For the membrane sys-
tem, a six-step equilibration (as given by Charmm-GUI) was
performed using 1- or 2-fs time steps. This was followed by
100-ns NPT production run (constant pressure/temperature)
at 300 K using 2-fs time step. The pressure was controlled using
the Nose-Hoover Langevin-piston method. Similarly, the tem-
perature was controlled using the Langevin temperature cou-
pling with a friction coefficient of 1 ps1. The VMD software
(39) was used to visualize and analyze the simulations.
Lipidmonolayer insertion experiment
Monolayer insertion experiments were performed as de-
scribed in Ref. 40. Briefly, a circular Teflon trough was filled
with Tris buffer (10 mM Tris, 150 mM KCl, 0.2 mM EDTA at pH
7.2). Total volumewas 6.5ml. The phospholipidmonolayerwas
formed on the air/water interface by adding phospholipids of
thementioned compositions dissolved in chloroform:methanol
(2:1) solvent in a dropwise manner using a 10-l Hamilton
syringe. Following establishment of a desired initial surface
pressure, chloroform was allowed to evaporate before intro-
ducingmVP40 protein into the subphase by injecting through a
port on the trough. Concentration of protein introduced to the
subphase was 0.12 M. The change in the surface pressure with
time was measured using a PlatinumWilhelmy plate and a PS4
Nima surface pressure sensor. The increase of the surface pres-
sure following addition of the protein was plotted as a function
of initial surface pressure of the monolayer. MIP value was
obtained by extrapolating to the x axis (23, 40).
Surface plasmon resonance binding assays
All SPR experiments were performed as previously described
in Refs. 41 and 42. Briefly, a POPC:POPS (60:40) active surface
and a POPC control surface or a POPC:PI(4,5)P2 (92.5:7.5)
active surface and a POPC control surface was used to deter-
mine the saturation response for the wild type and two mutant
mVP40 proteins at 500 nM concentrations.
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designed the studies. K. J. W., S. U., N. B., P. P. C., and S. L. per-
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